H376/95: Phase II

In a 600-patient Phase II study comparing H376/95 to Aventis

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE